Status:
COMPLETED
New Reusable Mask Design With Superior Filtration and Fit
Lead Sponsor:
Mayo Clinic
Conditions:
Covid19
Tuberculosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study will test the filtration, air leak, and breathability of a newly designed fully washable mask developed by Dr. Nordell with the Mayo Clinic. This mask is theorized to be a superior alternat...
Detailed Description
The purpose of this study is to determine potential effectiveness of a new, reusable mask against SARS-CoV-2 and other microbes. This requires filtering down to at least 0.3 microns, as the SARS-CoV-2...
Eligibility Criteria
Inclusion
- Current employee of Mayo Clinic Health System-Mankato
- Passed N95 fit test within the past year
- No medical history of: high blood pressure, current or recent pneumonia or upper respiratory infection, and no uncontrolled chronic asthma
- Ideally with wide representation of genders, race, age, BMI, occupation/role in hospital.
- Willing and able to provde verbal consent.
Exclusion
- \- History of uncontrolled asthma, pneumonia, or hypertension.
Key Trial Info
Start Date :
April 9 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2022
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04826809
Start Date
April 9 2021
End Date
October 27 2022
Last Update
July 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Health System in Mankato
Mankato, Minnesota, United States, 56001